Follow
Xinwei Han
Xinwei Han
FogPharma
Verified email at fogpharma.com
Title
Cited by
Cited by
Year
SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research
SPARK Consortium
Neuron 97 (3), 488-493, 2018
303*2018
High-resolution expression map of the Arabidopsis root reveals alternative splicing and lincRNA regulation
S Li, M Yamada, X Han, U Ohler, PN Benfey
Developmental cell 39 (4), 508-522, 2016
2692016
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient …
A Oaknin, L Gilbert, AV Tinker, J Brown, C Mathews, J Press, R Sabatier, ...
Journal for immunotherapy of cancer 10 (1), 2022
1812022
Unique cell-type-specific patterns of DNA methylation in the root meristem
T Kawakatsu, T Stuart, M Valdes, N Breakfield, RJ Schmitz, JR Nery, ...
Nature plants 2 (5), 1-8, 2016
1792016
Analysis of Arabidopsis genome-wide variations before and after meiosis and meiotic recombination by resequencing Landsberg erecta and all four products of a single meiosis
P Lu, X Han, J Qi, J Yang, AJ Wijeratne, T Li, H Ma
Genome Research 22 (3), 508-518, 2012
1532012
RGF1 controls root meristem size through ROS signalling
M Yamada, X Han, PN Benfey
Nature 577 (7788), 85-88, 2020
1452020
Transcriptome of embryonic and neonatal mouse cortex by high-throughput RNA sequencing
X Han, X Wu, WY Chung, T Li, A Nekrutenko, NS Altman, G Chen, H Ma
Proceedings of the National Academy of Sciences 106 (31), 12741-12746, 2009
1002009
Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors
W Fu, H Lan, S Li, X Han, T Gao, D Ren
Cancer Gene Therapy 15 (7), 474-484, 2008
562008
Synergistic antitumoral effects of human telomerase reverse transcriptase‐mediated dual‐apoptosis‐related gene vector delivered by orally attenuated Salmonella enterica Serovar …
W Fu, L Chu, X Han, X Liu, D Ren
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008
432008
Distinct epigenomic patterns are associated with haploinsufficiency and predict risk genes of developmental disorders
X Han, S Chen, E Flynn, S Wu, D Wintner, Y Shen
Nature communications 9 (1), 2138, 2018
342018
Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
I Lodewijk, A Bernardini, C Suárez-Cabrera, E Bernal, R Sánchez, ...
NPJ Precision Oncology 6 (1), 7, 2022
122022
O007/# 456 Post-hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer …
A Tinker, R Sabatier, A Gravina, L Gilbert, J Brown, V Samouëlian, ...
International Journal of Gynecologic Cancer 32 (Suppl 3), 2022
62022
76P Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial
A Oaknin, L Gilbert, A Tinker, J Brown, C Mathews, JZ Press, R Sabatier, ...
Annals of Oncology 32, S388-S389, 2021
52021
Root meristem growth factor 1 controls root meristem size through reactive oxygen species signaling
M Yamada, X Han, PN Benfey
bioRxiv, 244947, 2018
52018
Antitumor activity of dostarlimab by PD-L1 and tumor mutation burden (TMB) in patients (pts) with mismatch repair deficient and proficient (dMMR and MMRp) tumors in the GARNET …
T Andre, S Banerjee, D Berton, SL Ellard, B Jimenez, V Samouelian, ...
Cancer Research 82 (12_Supplement), 5135-5135, 2022
32022
Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2.
PJ Keller, R Meyer, E Greenwald, X Han, AR Conery, JA Mertz, P Trojer
CLINICAL CANCER RESEARCH 26 (15), 40-40, 2020
22020
RNA: an expanding view of function and evolution
X Han, Y Chen, L Wang, W Fang, N Zhang, Q Zhu
Evolutionary Bioinformatics 11, EBO. S38105, 2015
12015
Antitumor activity of dostarlimab by PD-L1 and tumor mutation burden (TMB) in patients (pts) with mismatch repair deficient and proficient (dMMR and MMRp) tumors in the GARNET …
A Vogel, T Andre, S Banerjee, D Berton, SL Ellard, B Jimenez, ...
ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 3), 17-17, 2022
2022
2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study
AV Tinker, B Pothuri, L Gilbert, R Sabatier, J Brown, S Ghamande, ...
International Journal of Gynecologic Cancer 32 (Suppl 2), 2022
2022
2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial
S Banerjee, T André, D Berton, SL Ellard, B Jimenez, V Samouëlian, ...
International Journal of Gynecological Cancer 32 (Suppl 2), A410-A410, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20